This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Men More Likely Than Women To Commit Scientific Fraud

Misconduct Occurs Across the Career Spectrum, From Trainees to Senior Scientists

BRONX, N.Y., Jan. 22, 2013 /PRNewswire-USNewswire/ -- Male scientists are far more likely to commit fraud than females and the fraud occurs across the career spectrum, from trainees to senior faculty. The analysis of professional misconduct was co-led by a researcher at Albert Einstein College of Medicine ( of Yeshiva University and was published today in the online journal mBio.


"The fact that misconduct occurs across all stages of career development suggests that attention to ethical aspects of scientific conduct should not be limited to those in training, as is the current practice," said senior author  Arturo Casadevall, M.D., Ph.D. (, professor and chair of  microbiology & immunology ( and professor of  medicine ( at Einstein, as well as editor-in-chief of mBio.

He added, "Our other finding – that males are overrepresented among those committing misconduct – implies a gender difference we need to better understand in any effort to promote the integrity of research."

In a previous study (, Dr. Casadevall found that misconduct is responsible for two-thirds of all retractions of scientific papers. The finding was unexpected, since earlier research had suggested that errors account for the majority of retracted scientific papers.

Researchers embarked on the current study to better understand those who are guilty of scientific fraud. They reviewed 228 individual cases of misconduct reported by the United States Office of Research Integrity ( (ORI) from 1994 through 2012. ORI promotes the responsible conduct of research and investigates charges of misconduct involving research supported by the Department of Health and Human Services.

An analysis determined that fraud was involved in 215 (94 percent) of the 228 cases reported by the ORI. Of these, 40 percent involved trainees, 32 percent involved faculty members, and 28 percent involved other research personnel (research scientists, technicians, study coordinators, and interviewers).

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs